Pathway Genomics

The deal with Salud Interactiva will make Pathway's next-generation sequencing-based tests available in Mexico.

Researchers saw a small, but significant uptick in self-reported healthy eating and exercise frequency after 23andMe or Pathway Genomics DTC testing.

A new PGen study reports that nearly 6 percent of consumers made changes to their prescription medication based on pharmacogenomic testing. 

Under the terms of the agreement, M3 and G-TAC will promote 14 Pathway tests through G-TAC's personalized medicine platform connected to M3's physician network.

Researchers examined the patient-physician relationship after sharing personal genetic testing results and found that patients may have certain expectations.

Researchers from Brigham and Women's and Harvard surveyed more than 1,600 new customers of 23andMe or Pathway Genomics in the US, of whom 80 were adopted.

The company said it would use the funds to expand its genomic test pipeline, grow its sales force, and invest in new technologies for its laboratories.

The US Department of Justice sued the company for paying doctors to perform its genomic tests, and then obtaining government reimbursements.

The US Food and Drug Administration has sent a letter this week to Pathway Genomics regarding its liquid biopsy cancer screening test.

The agency has sent a letter to the company requesting a meeting to discuss the recently launched liquid biopsy test, saying it may run afoul of FDA rules and regulations. 

Pages

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.